Spots Global Cancer Trial Database for mineralocorticoid antagonists [aldosterone antagonists] causing adverse effects in therapeutic use
Every month we try and update this database with for mineralocorticoid antagonists [aldosterone antagonists] causing adverse effects in therapeutic use cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Outcome of Patients With Primary Aldosteronism | NCT04428827 | Primary Aldoste... Primary Aldoste... Primary Aldoste... Adrenalectomy; ... Mineralocortico... Mineralocortico... Cardiovascular ... Chronic Renal D... Hypokalemia | Unilateral adre... | 14 Years - 100 Years | Changi General Hospital |